Tag: vaccine

Covid-19 vaccine ‘best science news’ of 2020

by Nina LARSON Agence France-Presse GENEVA, Switzerland (AFP) — Data indicating that a vaccine being developed against Covid-19 is highly effective is the “best science news of the year”, a pharmaceutical industry association chief said, voicing hope that other vaccine candidates would show equally good results. “A vaccine that has 90 percent efficacy and is pretty safe, that is a historic breakthrough,” the head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Thomas […]

Continue Reading →

Planes, dry ice, pharmacies: the logistical challenges of Covid-19 vaccines

  by Ivan Couronne Agence France Presse WASHINGTON, United States (AFP) — The United States could be the first country to launch one of the most ambitious vaccine operations in history: distributing and administering up to 600 million doses of a Covid-19 vaccine in just a few months. Massive vaccine campaigns are nothing new — they have been carried out for decades in the fight against the measles and flu, for example. But stamping out […]

Continue Reading →

Pfizer CEO sold $5.6 million in stock on day of vaccine announcement

WASHINGTON, United States (AGP) — Pfizer CEO Albert Bourla sold $5.6 million of his stock in the US pharmaceutical company on the same day it announced promising results for its Covid-19 vaccine candidate, filings showed Wednesday. The company, however, has reportedly said the sale was part of a pre-arranged periodic divestment plan when the stock reaches a certain price. According to a disclosure with US market regulator SEC, Bourla sold 132,508 shares at $41.94 each […]

Continue Reading →

Russia says Sputnik V virus vaccine 92% effective

MOSCOW, Russia (AFP) — Russia’s Sputnik V coronavirus vaccine is 92 percent effective according to initial test results, its developers said on Wednesday, as Moscow races against its competitors in the West. The calculations were based on results from 16,000 individuals who received both doses of the vaccine, Russia’s health ministry, the state-run Gamaleya research center and the Russian Direct Investment Fund (RDIF) said in a statement. “The Sputnik V vaccine had an efficacy rate […]

Continue Reading →

PHL had talks for acquisition of COVID vaccines from Pfizer at lower prices – Amb. Romualdez

Says vaccines from other US pharma might also be available by early next year to PHL https://youtu.be/UmP4v5Lo2uU (Eagle News) — The Philippines has already coordinated with the United States government for the acquisition of the COVID-19 vaccine jointly developed by Pfizer and BioNTech which has recently shown promise in preventing COVID-19 infections. And Pfizer is even willing to sell the vaccines to the Philippine government at a much lower price — at around $5 per […]

Continue Reading →

Sinovac says it is ‘confident’ of vaccine safety after Brazil trial halted

BEIJING, China (AFP) — Chinese pharmaceutical firm Sinovac Biotech on Tuesday stood by the safety of its Covid-19 vaccine after Brazilian regulators halted trials in the South American country citing an “adverse incident” involving a volunteer recipient. “We are confident in the safety of the vaccine,” Sinovac said in a statement, adding that the adverse incident was “unrelated to the vaccine”. © Agence France-Presse

Continue Reading →

Pres. Duterte approves “vaccine road map”; options for vaccine acquisition laid down

  (Eagle News) — President Rodrigo Duterte has approved the National Task Force’s (NTF) Philippine National Vaccine Roadmap which will ensure that the safest and most effective vaccine would be given to Filipinos. Presidential Spokesperson Harry Roque said that three options are also being discussed for the acquisition of the vaccine: through government to government deals, tripartite and multilateral deals where the pooled acquisition of COVID-19 vaccines by the ASEAN could be done to be […]

Continue Reading →

Brazil halts trials of Chinese Covid-19 vaccine

RIO DE JANEIRO, Brazil (AFP) — Brazil’s health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an “adverse incident” involving a volunteer recipient, a blow for one of the most advanced vaccine candidates. The regulator, Anvisa, said in a statement it had “ruled to interrupt the clinical trial of the CoronaVac vaccine after a serious adverse incident” on October 29. It said it could not give details on what […]

Continue Reading →

Scientist behind mRNA vaccine innovation hails Pfizer breakthrough

by Issam AHMED WASHINGTON, United States (AFP) — A scientist who invented a technique that paved the way for Pfizer and BioNTech’s Covid-19 vaccine hailed the interim results announced by the companies Monday as “fantastic” and said the pioneering approach had a bright future. Drew Weissman, an immunologist at the University of Pennsylvania, told AFP: “I can’t remember the last respiratory virus vaccine that has over 90 percent efficacy,” referring to the rate at which […]

Continue Reading →

Pfizer says Covid-19 vaccine 90% effective in Phase 3 trial

PARIS, France (AFP) — A vaccine jointly developed by Pfizer and BioNTech was 90 percent effective in preventing Covid-19 infections in ongoing Phase 3 trials, the companies announced Monday. Protection in patients was achieved seven days after the second of two doses, and 28 days after the first, according to preliminary findings. “The first set of results from our Phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19,” […]

Continue Reading →

Moderna already has $1.1 bn in deposits for Covid-19 vaccine

NEW YORK, United States (AFP) — Moderna said Thursday it took in $1.1 billion in deposits in the third quarter for a coronavirus vaccine that it is “actively preparing” to launch. The biotech company, releasing quarterly results, completed its enrollment earlier this month for the phase-3 trial of “mRNA-1273,” a vaccine candidate for Covid-19. “We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around […]

Continue Reading →

Pfizer says Covid-19 vaccine still possible in 2020 despite data lag

NEW YORK, United States (AFP) — Pfizer executives expressed measured optimism Tuesday over the prospect of providing a coronavirus vaccine in 2020 even as they signaled key data on the vaccine would not be released before the US election. Pfizer Chief Executive Albert Bourla said the drug giant could supply some 40 million doses in the United States in 2020 if clinical testing proceeds as expected and regulators approve a vaccine. “If all goes well, […]

Continue Reading →
1 … 62 63 64 65 66 … 77